The identification of chemical compounds that decrease cellular levels of toxic Huntington's disease protein through a novel cell-based assay
Year: 2006
Type: dissertation
Abstract: Huntington's disease (HD) is a progressive degenerative neurological disorder. Individuals who inherit the IT15 gene with an expansion of the CAG repeat region inevitably succumb to increasingly sever motor, psychological, and cognitive symptoms. I sought to develop an assay system with the capability for identification of chemical compounds that selectively decrease the intracellular levels of disease-causing expanded polyglutamine huntingtin (Htt) protein without reducing the intracellular levels of the potentially protective normal Htt. To achieve this goal I designed a cell-based assay using the enzymatic activity of E. coli [beta]-galactosidase as a reporter for Htt protein levels. I expressed either expanded (97Q) or normal (23Q) Htt fused to the [beta]-galactosidase alpha-subunit ([alpha]) in an inducible fashion in PC12 cells which also expressed the [beta]-galactosidase delta-subunit ([delta]). Complementation between these expressed subunits allowed the formation of functional P-galactosidase. The level of [beta]-galactosidase activity in these [delta]-[alpha]97Q and [delta]-[alpha]23Q cells directly correlated with the amount of a 97Q and a 23Q fusion protein levels, indicating that [beta]-galactosidase activity could be used as a reporter in this system for Htt protein levels.
Author: Myra Coufal
Institution: Massachusetts Institute of Technology
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W1488379092
